First Patient Dosed with NILK-2301 in Phase I Clinical Trial
First Patient Dosed with NILK-2301 in Phase I Clinical Trial Read More »
The START Center for Cancer Research (“START”) is set to have a significant presence at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting. Known for our commitment to the advancement of cancer research and treatment, we are excited to share that our team of Principal Investigators (PIs) will be involved in nearly 100
New CEO Nick Slack selected to lead the organization in its next phase of growth SAN ANTONIO–(BUSINESS WIRE)–The START Center for Cancer Research, the world’s largest global site network of early phase oncology clinical trials, sets its sights on expanding access to breakthrough research to all communities globally. Currently running one of the largest portfolios